There is great variety within each these two patient groups and it would be very beneficial if DTI can detect early the effects of growth hormone therapy Growth hormone resistance is associated with chronic liver disease, for example Alagille syndrome, and standard growth hormone replacement has little effect on serum IGF-1.32 This evidence concerns the gene IGF1 and Alagille syndrome.